Why Goldman Might Be Cutting Marcus Lending Goal

Why Goldman Might Be Cutting Marcus Lending Goal

Assessment

Interactive Video

Business

University

Hard

Created by

Quizizz Content

FREE Resource

The transcript discusses Goldman Sachs' strategy with its consumer lending platform, Marcus. It highlights the company's cautious approach in response to a potentially changing credit cycle. Goldman Sachs, traditionally focused on corporate clients, is now venturing into personal loans, which is outside its usual domain. The company has seen rapid growth but is now considering scaling back new loan originations as a prudent step. This move reflects their adaptation to market conditions and strategic planning for future consumer lending.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is one reason Goldman Sachs might be cautious about expanding Marcus?

The credit cycle is short.

They have a surplus of funds.

The credit cycle has been extended.

They are focusing on corporate loans.

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What has been the initial performance of Marcus in the consumer lending market?

It has had a rapid start with significant lending.

It has only focused on corporate clients.

It has struggled to find demand.

It has faced regulatory issues.

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Why is Goldman Sachs scaling back on new loan originations?

Due to a lack of demand.

To focus on secured loans.

Because of high default rates.

To manage potential market changes.

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

How does the personal loan market fit into Goldman Sachs' traditional business model?

It aligns with their corporate lending strategies.

It is a completely new venture for them.

It is a natural extension of their services.

It is a minor part of their operations.

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is a challenge Goldman Sachs faces with its new strategy in personal loans?

Competition from other banks.

Inability to secure funding.

Skepticism from the market.

Lack of interest from consumers.